NCT05030571View on ClinicalTrials.gov

The Effects of Double Plasma Molecular Adsorption System in Acute on Chronic Liver Failure Patients

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

January 1, 2025

Study Completion Date

December 1, 2025

Conditions
Acute-On-Chronic Liver FailureAcute on Chronic Hepatic Failure
Interventions
DEVICE

DPMAS

DPMAS circuit consist of Plasmaflo OP cartridge (Asahi Medical, Tokyo, Japan), Ion exchange resin hemoperfusion cartridge (BS330; Jafron, Zhuhai City, China), and Neutral adsorption resin hemoperfusion cartridge (HA330-II; Jafron, Zhuhai City, China)

OTHER

standard treatment

standard treatment according to EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure 2017.

Trial Locations (1)

Unknown

RECRUITING

King Chulalongkorn Memorial Hospital, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER